Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
- 1 October 1990
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 40 (4), 498-530
- https://doi.org/10.2165/00003495-199040040-00003
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1990
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- Thrombolysis in the Management of Acute Myocardial Infarction and Unstable Angina PectorisDrugs, 1989
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mgThe Journal of Clinical Pharmacology, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Effect of Low-Molecular-Weight Heparins on Laser-Induced Thrombus Formation in Rat Mesenteric VesselsPathophysiology of Haemostasis and Thrombosis, 1988
- Heparin versus Low Molecular Weight Heparin K 2165 in Chronic Hemodialysis Patients: A Randomized Cross-Over StudyPathophysiology of Haemostasis and Thrombosis, 1986
- Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1979